HDAC6 promotes cell proliferation and confers resistance to temozolomide in glioblastoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

HDAC6 promotes cell proliferation and confers resistance to temozolomide in glioblastoma

Published:2016-08 Issue:1 Volume:379 Page:134-142
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Wang Zhihao,Hu Pengchao,Tang Fang,Lian Haiwei,Chen Xiong,Zhang Yingying,He Xiaohua,Liu Wanhong,Xie Conghua

Funder

Natural Sciences Foundation of Hubei Province

National Natural Sciences Foundation of China

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference51 articles.

1. Development of novel targeted therapies in the treatment of malignant glioma;Rich;Nat. Rev. Drug Discov,2004

2. SnapShot: glioblastoma multiforme;Kotliarova;Cancer Cell,2012

3. Current challenges in glioblastoma: intratumour heterogeneity, residual disease, and models to predict disease recurrence;Ellis;Front. Oncol,2015

4. Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer;Minucci;Nat. Rev. Cancer,2006

5. Targeting of histone deacetylases in brain tumors;Ecker;CNS Oncol,2013

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Andrographolide sensitizes glioma to temozolomide by inhibiting DKK1 expression;British Journal of Cancer;2024-09-12

2. Discovery of Potent Selective HDAC6 Inhibitors with 5-Phenyl-1H-indole Fragment: Virtual Screening, Rational Design, and Biological Evaluation;Journal of Chemical Information and Modeling;2024-07-23

3. Temozolomide (TMZ) in the Treatment of Glioblastoma Multiforme—A Literature Review and Clinical Outcomes;Current Oncology;2024-07-12

4. Targeting drug resistance in glioblastoma (Review);International Journal of Oncology;2024-07-09

5. Targeting histone deacetylase 6 (HDAC6) to enhance radiation therapy in meningiomas in a 2D and 3D in vitro study;eBioMedicine;2024-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3